Bernstein U.S. Research Fund Stock Forecast, Price & News

0.00 (0.00 %)
(As of 08/19/2019)
Today's Range
50-Day Range
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BERN News and Ratings via Email

Sign-up to receive the latest news and ratings for Bernstein U.S. Research Fund and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Exchange Traded Concepts
Fund NameBernstein US Research Fund
Tax ClassificationRegulated Investment Company
Inception Date10/16/2017
Fund ManagerDenise M. Krisko

Fund Focus

Asset ClassEquity
BenchmarkBernstein U.S. Research Index
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$7.21 million
Average Daily Volume$383.80

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver0.00%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorSEI Investments Global Funds Services
AdvisorExchange Traded Concepts, LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
Lead Market MakerCantor Fitzgerald

speech bubbles
speech bubbles

Bernstein U.S. Research Fund (BATS:BERN) Frequently Asked Questions

What stocks does MarketBeat like better than Bernstein U.S. Research Fund?

Wall Street analysts have given Bernstein U.S. Research Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bernstein U.S. Research Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Bernstein U.S. Research Fund's stock price been impacted by COVID-19 (Coronavirus)?

Bernstein U.S. Research Fund's stock was trading at $28.8250 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BERN stock has increased by 0.0% and is now trading at $28.8250.
View which stocks have been most impacted by COVID-19

Who are some of Bernstein U.S. Research Fund's key competitors?

What other stocks do shareholders of Bernstein U.S. Research Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bernstein U.S. Research Fund investors own include Gilead Sciences (GILD), New Residential Investment (NRZ), SMART Global (SGH), Brookfield Infrastructure Partners (BIP), Big Lots (BIG), Bank of America (BAC), Alibaba Group (BABA), (AZN), Liberty All-Star Growth Fund (ASG) and Ares Capital (ARCC).

What is Bernstein U.S. Research Fund's stock symbol?

Bernstein U.S. Research Fund trades on the BATS under the ticker symbol "BERN."

How do I buy shares of Bernstein U.S. Research Fund?

Shares of BERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bernstein U.S. Research Fund's stock price today?

One share of BERN stock can currently be purchased for approximately $28.83.

This page was last updated on 9/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.